Guangzhou Han
Seminars
Wednesday 2nd December 2026
Does Every Target Need the Same Radionuclide? Rethinking Isotope Selection for the Next Generation of Radiopharmaceuticals
11:00 am
- Discovering why radionuclide selection should be driven by target biology, tumour characteristics and pharmacokinetics rather than platform familiarity
- Examining how different isotopes may influence therapeutic index, dosimetry, manufacturability and ultimately clinical success across diverse target classes
- Sharing lessons from designing next-generation theranostic programmes where isotope selection is considered alongside target selection from the earliest stages
